PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity

DSpace Repository

PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity

Author: Moraes Ribeiro, Emmanuelle; Secker, Kathy-Ann; Nitulescu, Ana-Maria; Schairer, Rebekka; Keppeler, Hildegard; Wesle, Anton; Schmid, Hannes; Schmitt, Anita; Neuber, Brigitte; Chmiest, Daniela; Podavini, Silvia; Maerklin, Melanie; Klimovich, Boris; Schmitt, Michael; Korkmaz, Fulya; Lengerke, Claudia; Schneidawind, Corina; Schneidawind, Dominik
Tübinger Autor(en):
Moraes Ribeiro, Emmanuelle
Secker, Kathy-Ann
Nitulescu, Ana-Maria
Schairer, Rebekka
Keppeler, Hildegard
Wesle, Anton
Schmid, Hannes
Maerklin, Melanie
Klimovich, Boris
Korkmaz, Fulya
Lengerke, Claudia
Schneidawind, Corina
Schneidawind, Dominik
Published in: Journal For Immunotherapy of Cancer (2024), Bd. 12, H. 1
Verlagsangabe: London : Bmj Publishing Group
Language: English
Full text: http://dx.doi.org/10.1136/jitc-2023-007829
ISSN: 2051-1426
DDC Classifikation: 610 - Medicine and health
570 - Life sciences; biology
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)